Showing results (11-20 of 477) with videos related to
Sort By:
Pageof 48
International Journal of Hematology|July 9, 2004
Imatinib mesylate in the treatment of chronic myelogenous leukemiaGautam Borthakur, Jorge E CortesLeukemia & Lymphoma|July 18, 2023
IDH2 mutations in acute myeloid leukemiaRodrick Babakhanlou, Courtney DiNardo, Gautam BorthakurClinical Advances in Hematology & Oncology : H&O|August 2, 2018
Bromodomain inhibitors: what does the future hold?Seemana Bhattacharya, Sujan Piya, Gautam BorthakurExpert Opinion on Investigational Drugs|September 1, 2009
Clofarabine: emerging role in leukemiasKeeran Sampat, Hagop Kantarjian, Gautam BorthakurAutophagy|November 1, 2016
Targeting autophagy to overcome chemoresistance in acute myleogenous leukemiaSujan Piya, Michael Andreeff, Gautam BorthakurCurrent Oncology Reports|August 21, 2007
Therapy-related acute myelogenous leukemia and myelodysplastic syndromeGautam Borthakur, And Elihu E EsteyLeukemia & Lymphoma|November 9, 2020
Bromodomain and extra-terminal (BET) inhibitors in treating myeloid neoplasmsNatalie Cheng Chen, Gautam Borthakur, Naveen PemmarajuExpert Opinion on Investigational Drugs|April 17, 2013
XIAP antisense therapy with AEG 35156 in acute myeloid leukemiaLakshmikanth Katragadda, Bing Z Carter, Gautam BorthakurLeukemia Research Reports|October 25, 2021
Sustained MRD negative remission in del17p and TP53 mutated B cell prolymphocytic leukemia with ibrutinib and venetoclaxMaria Tariq Siddiqui, Allyson Price, Alessandra Ferrajoli, et al.Expert Opinion on Pharmacotherapy|May 29, 2019
Topoisomerase II inhibitors in AML: past, present, and futureMinas P Economides, Deborah McCue, Gautam Borthakur, et al.Pageof 48